tradingkey.logo

Apyx Medical Corp

APYX

1.770USD

+0.020+1.14%
Horário de mercado ETCotações atrasadas em 15 min
66.90MValor de mercado
PerdaP/L TTM

Apyx Medical Corp

1.770

+0.020+1.14%
Mais detalhes de Apyx Medical Corp Empresa
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.
Informações da empresa
Código da empresaAPYX
Nome da EmpresaApyx Medical Corp
Data de listagemJul 22, 1983
CEOMr. Charles D. Goodwin, II
Número de funcionários220
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 22
Endereço5115 Ulmerton Rd
CidadeCLEARWATER
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal33760-4004
Telefone18005372790
Sitehttps://apyxmedical.com/
Código da empresaAPYX
Data de listagemJul 22, 1983
CEOMr. Charles D. Goodwin, II
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Domestic
6.74M
71.51%
International
2.69M
28.49%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: seg, 28 de jul
Atualizado em: seg, 28 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Nantahala Capital Management, LLC
9.24%
Vanderfelt (William Weeks)
8.36%
Archon Capital Management LLC
8.24%
Royce Investment Partners
6.83%
Vizirgianakis (Stavros G)
4.62%
Other
62.70%
Investidores
Investidores
Proporção
Nantahala Capital Management, LLC
9.24%
Vanderfelt (William Weeks)
8.36%
Archon Capital Management LLC
8.24%
Royce Investment Partners
6.83%
Vizirgianakis (Stavros G)
4.62%
Other
62.70%
Tipos de investidores
Investidores
Proporção
Hedge Fund
18.35%
Individual Investor
14.56%
Investment Advisor
13.15%
Investment Advisor/Hedge Fund
11.82%
Private Equity
0.40%
Research Firm
0.07%
Family Office
0.05%
Other
41.60%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
116
22.05M
58.35%
-4.12M
2025Q1
125
22.61M
59.94%
-6.15M
2024Q4
130
22.74M
56.04%
-3.63M
2024Q3
136
20.12M
55.21%
-8.55M
2024Q2
151
21.12M
58.12%
-8.52M
2024Q1
177
21.34M
61.14%
-7.38M
2023Q4
188
22.63M
64.87%
-7.08M
2023Q3
183
23.85M
68.61%
-6.50M
2023Q2
175
23.83M
68.55%
-8.83M
2023Q1
178
25.32M
73.20%
-1.68M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Nantahala Capital Management, LLC
3.49M
9.24%
+235.19K
+7.22%
Jun 23, 2025
Vanderfelt (William Weeks)
3.16M
8.36%
--
--
Jun 23, 2025
Archon Capital Management LLC
3.12M
8.24%
-181.46K
-5.50%
Jun 23, 2025
Royce Investment Partners
2.58M
6.83%
+57.02K
+2.26%
Jun 23, 2025
Vizirgianakis (Stavros G)
1.75M
4.62%
--
--
Jun 23, 2025
The Vanguard Group, Inc.
1.48M
3.9%
--
--
Mar 31, 2025
Silverberg Bernstein Capital Management, LLC
646.57K
1.71%
+75.34K
+13.19%
Mar 31, 2025
Horizon Kinetics LLC
615.00K
1.63%
--
--
Mar 31, 2025
Commonwealth Financial Network
585.54K
1.55%
+58.48K
+11.10%
Mar 31, 2025
Worth Venture Partners, LLC
518.20K
1.37%
+55.59K
+12.02%
Dec 31, 2023
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proporção0.02%
Avantis US Equity ETF
Proporção0%
Invesco NASDAQ Future Gen 200 ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI